R-Zero, a biosafety technology company dedicated to reducing the spread of infectious disease, announced a $41.5 million Series B investment.

The round was led by World Innovation Lab (WiL) with participation from venture capital icon John Doerr and current R-Zero investors, DBL Partners and SOSV / HAX. This latest investment brings R-Zero's total capital raised to over $58 million

R-Zero Systems is the first company built from the ground up to tackle the transmission of pathogens in the COVID-19 era, making UV-C disinfection technologies accessible to all. Founded to help organizations protect what matters most, R-Zero's suite of thoughtfully-designed, hospital-grade technologies and science-backed protocols reduce the transmission of pathogens and diseases they cause - from the coronavirus to the common cold.